DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
A recent study published in the Annals of Rheumatic Disease has concluded that the immunogenicity to CoronoVac is moderate in patients with RA receiving DMARDs. …
You must be logged in to post a comment.